Phase I Study of Marizomib + Panobinostat for Children With DIPG

Clinical trial NCT04341311 · TERMINATED

Trial details

NCT number: NCT04341311
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Pediatric Brainstem Glioma Pediatric Brainstem Gliosarcoma, Recurrent Pediatric Cancer Pediatric Brain Tumor Diffuse Glioma

Start date: 2020-08-10
Primary completion: 2024-02-14
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.